Dyslipidemia Therapeutics Market to Represent Significant Revenue Growth 2017–2025
The global market for dyslipidemia therapeutics is expected to be driven by the increasing incidence of dyslipidemia and cardiovascular disease, growing obese population prone to cardiovascular disease due to sedentary lifestyle. Few of the drivers of the market are the growing R&D activities by leading players for the development of novel drugs, increasing diagnosis rate among patient population and increasing awareness in developing economies. Moreover, the increasing research activities on stain and non-stain based therapeutics for cardiovascular and associated disease,...
View full press release